DocGo Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
DocGo Inc. (DCGO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $57.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-16
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2023-12-31 was $736.56K.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2023-09-30 was -$2.34M.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-12-31 was -$15.18M.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-09-30 was $0.00.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $57.45M, a 1053.66% increase from fiscal 2024.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $4.98M.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$312.67K.
- DocGo Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$15.18M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $57.45M 10-K · filed 2026-03-16 | |||
| 2024-12-31 | $4.98M 10-K · filed 2026-03-16 | |||
| 2023-12-31 | $736.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.60M derived: sum of 2 quarters · filed 2025-02-27 | -$312.67K 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.05M 10-Q · filed 2023-11-06 | ||
| 2023-06-30 | $1.29M 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | -$15.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$15.18M derived: sum of 2 quarters · filed 2024-02-28 | -$15.18M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |